Monash IVF Group Limited

ASX MVF.AX

Monash IVF Group Limited Shares (Diluted, Weighted) for the year ending June 30, 2024: 389,634,840

Monash IVF Group Limited Shares (Diluted, Weighted) is 389,634,840 for the year ending June 30, 2024, a -0.71% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Monash IVF Group Limited Shares (Diluted, Weighted) for the year ending June 30, 2023 was 392,425,323, a 0.23% change year over year.
Monash IVF Group Limited Shares (Diluted, Weighted) for the year ending June 30, 2022 was 391,543,005, a 0.15% change year over year.
Monash IVF Group Limited Shares (Diluted, Weighted) for the year ending June 30, 2021 was 390,944,732, a 19.77% change year over year.
Monash IVF Group Limited Shares (Diluted, Weighted) for the year ending June 30, 2020 was 326,411,284, a 0.00% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

ASX: MVF.AX

Monash IVF Group Limited

CEO	Mr. Michael D. Knaap
IPO Date	June 26, 2014
Location	Australia
Headquarters	Pelaco Building 1
Employees	997
Sector	Healthcare
Industries Biotechnology 3D Printing Clinical Trials Dental Care Medical Instruments Professional Services Telehealth Venture Capital

Description

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. The company was incorporated in 2014 and is based in Richmond, Australia.

Key trends

Past 5 years